Canaccord Genuity Maintains Hold on Edwards Lifesciences, Lowers Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst William Plovanic maintains a Hold rating on Edwards Lifesciences (NYSE:EW) and lowers the price target from $85 to $77.
July 25, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity analyst William Plovanic maintains a Hold rating on Edwards Lifesciences and lowers the price target from $85 to $77.
The lowered price target from $85 to $77 by Canaccord Genuity suggests a less optimistic outlook for Edwards Lifesciences, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100